Intrinsiqs

Is Neumora Therapeutics, Inc. Common Stock overvalued?

Neumora Therapeutics, Inc. Common Stock (NMRA) — key valuation metrics and fundamentals.

No verdict
Price
$1.69
Fair value
Current P/E
Normal P/E
Market cap
$315.9M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares NMRA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.